| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GPL21290
|
||||||||
| GSM8110906 |
WT_M238, untreated, mRNA-Seq, clone1
|
SRA | 1 |
|
Prabhat Kumar Purbey | May 01, 2024 | |||
| GSM8110907 |
WT_M238, untreated, mRNA-Seq, clone2
|
SRA | 1 |
|
Prabhat Kumar Purbey | May 01, 2024 | |||
| GSM8110908 |
IRF1KO_M238,untreated, mRNA-Seq, clone1
|
SRA | 1 |
|
Prabhat Kumar Purbey | May 01, 2024 | |||
| GSM8110909 |
IRF1KO_M238,untreated, mRNA-Seq, clone2
|
SRA | 1 |
|
Prabhat Kumar Purbey | May 01, 2024 | |||
| GSM8110910 |
WT_M238_6h-IFNG, mRNA-Seq, clone1
|
SRA | 1 |
|
Prabhat Kumar Purbey | May 01, 2024 | |||
| GSM8110911 |
WT_M238_6h-IFNG, mRNA-Seq, clone2
|
SRA | 1 |
|
Prabhat Kumar Purbey | May 01, 2024 | |||
| GSM8110912 |
IRF1KO_M238_6h-IFNG, mRNA-Seq, clone1
|
SRA | 1 |
|
Prabhat Kumar Purbey | May 01, 2024 | |||
| GSM8110913 |
IRF1KO_M238_6h-IFNG, mRNA-Seq, clone2
|
SRA | 1 |
|
Prabhat Kumar Purbey | May 01, 2024 | |||
| GSM7807670 |
A549 human lung carcinoma, RNaseL_KO, polyIC, 2
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7807672 |
A549 human lung carcinoma, WT, 25A, 2
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7807673 |
A549 human lung carcinoma, WT, 25A, 3
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7807674 |
A549 human lung carcinoma, WT, None, 1
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7807675 |
A549 human lung carcinoma, WT, None, 2
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7807676 |
A549 human lung carcinoma, WT, polyIC, 1
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7807677 |
A549 human lung carcinoma, WT, polyIC, 2
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7808337 |
A549 human lung carcinoma, RNaseL_KO, Rnase A, 4.5h, rep1
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7808338 |
A549 human lung carcinoma, RNaseL_KO, BSA, 4.5h, rep1
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7808339 |
A549 human lung carcinoma, RNaseL_KO, BSA, 4.5h, rep2
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM7808340 |
A549 human lung carcinoma, RNaseL_KO, Rnase A, 4.5h, rep2
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 | |||
| GSM8188695 |
A549 human lung carcinoma, WT, Lipofectamine (Control), 4.5h, 1
|
SRA | 1 |
|
Nicholas R Guydosh | Apr 30, 2024 |
